Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2) (C-Term) Peptide
-
- Target See all IMPA2 products
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
- Protein Region
- C-Term
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GAFCNGQRLQ VSRETDLAKA LVLTEIGPKR DPDTLKVFLS NMERLLHAKA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Impa2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IMPA2 (Inositol(myo)-1(or 4)-Monophosphatase 2 (IMPA2))
- Synonyms
- zgc:110201 Peptide, 2210415D20Rik Peptide, AI326924 Peptide, AW259601 Peptide, inositol monophosphatase 2 Peptide, inositol(myo)-1(or 4)-monophosphatase 2 Peptide, inositol (myo)-1(or 4)-monophosphatase 2 Peptide, IMPA2 Peptide, impa2 Peptide, MGYG_08537 Peptide, Impa2 Peptide
- Background
-
Impa2 can use myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. Impa2 has been implicated as the pharmacological target for lithium Li+ action in brain.
Alias Symbols: 2210415D20Rik, AI326924, AW259601
Protein Size: 290 - Molecular Weight
- 32 kDa
- Gene ID
- 114663
- NCBI Accession
- NM_053261, NP_444491
- UniProt
- Q91UZ5
-